Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-07 1:51 pm Sale |
2024-12-31 | 13G | ADMA Biologics, Inc. ADMA |
Invesco Ltd. IVZ |
11,296,255 4.800% |
-1,323,514 (-10.49%) |
Filing History |
| 2024-11-12 1:34 pm Unchanged |
2024-09-30 | 13G | ADMA Biologics, Inc. ADMA |
The Vanguard Group | 18,118,494 7.770% |
0 (Unchanged) |
Filing History |
| 2024-11-08 09:21 am Purchase |
2024-11-08 | 13G | ADMA Biologics, Inc. ADMA |
Invesco Ltd. IVZ |
12,619,769 5.500% |
12,619,769 (New Position) |
Filing History |
| 2024-11-04 11:00 am Purchase |
2024-09-30 | 13G | ADMA Biologics, Inc. ADMA |
The Vanguard Group | 18,118,494 7.770% |
5,226,619 (+40.54%) |
Filing History |
| 2024-10-17 09:22 am Purchase |
2024-09-30 | 13G | ADMA Biologics, Inc. ADMA |
STATE STREET CORP STT |
13,004,993 5.600% |
13,004,993 (New Position) |
Filing History |
| 2024-10-07 4:08 pm Purchase |
2024-09-30 | 13G | ADMA Biologics, Inc. ADMA |
BLACKROCK INC BLK |
38,269,434 16.400% |
20,351,689 (+113.58%) |
Filing History |
| 2024-09-23 4:27 pm Sale |
2024-09-19 | 13G | ADMA Biologics, Inc. ADMA |
MILLENNIUM MANAGEMENT LLC | 1,374,038 0.600% |
-4,880,371 (-78.03%) |
Filing History |
| 2024-03-11 12:31 pm Sale |
2024-02-29 | 13G | ADMA Biologics, Inc. ADMA |
Teachers Advisors, LLC | 4,955,411 2.170% |
-107,134 (-2.12%) |
Filing History |
| 2024-03-11 12:24 pm Sale |
2024-02-29 | 13G | ADMA Biologics, Inc. ADMA |
TIAA-CREF Investment Management, LLC | 4,955,411 2.170% |
-107,134 (-2.12%) |
Filing History |
| 2024-03-11 12:19 pm Sale |
2024-02-29 | 13G | ADMA Biologics, Inc. ADMA |
Nuveen Asset Management, LLC | 4,955,411 2.170% |
-107,134 (-2.12%) |
Filing History |
| 2024-02-14 4:49 pm Sale |
2023-12-31 | 13G | ADMA Biologics, Inc. ADMA |
PERCEPTIVE ADVISORS LLC | 6,433,369 2.800% |
-5,466,886 (-45.94%) |
Filing History |
| 2024-02-14 11:50 am Sale |
2023-12-31 | 13G | ADMA Biologics, Inc. ADMA |
Nuveen Asset Management, LLC | 5,062,545 2.240% |
-420,824 (-7.67%) |
Filing History |
| 2024-02-14 11:47 am Sale |
2023-12-31 | 13G | ADMA Biologics, Inc. ADMA |
Teachers Advisors, LLC | 5,062,545 2.240% |
-420,824 (-7.67%) |
Filing History |
| 2024-02-14 11:37 am Sale |
2023-12-31 | 13G | ADMA Biologics, Inc. ADMA |
TIAA-CREF Investment Management, LLC | 5,062,545 2.240% |
-420,824 (-7.67%) |
Filing History |
| 2024-02-13 4:56 pm Purchase |
2023-12-29 | 13G | ADMA Biologics, Inc. ADMA |
The Vanguard Group | 12,891,875 5.710% |
12,891,875 (New Position) |
Filing History |
| 2024-01-26 11:49 am Purchase |
2023-12-31 | 13G | ADMA Biologics, Inc. ADMA |
BLACKROCK INC BLK |
17,917,745 7.900% |
2,816,464 (+18.65%) |
Filing History |
| 2023-02-14 2:31 pm Sale |
2022-12-31 | 13G | ADMA Biologics, Inc. ADMA |
PERCEPTIVE ADVISORS LLC | 11,900,255 5.400% |
-33,132 (-0.28%) |
Filing History |
| 2023-02-14 08:50 am Purchase |
2022-12-31 | 13G | ADMA Biologics, Inc. ADMA |
Nuveen Asset Management, LLC | 5,483,369 2.480% |
5,483,369 (New Position) |
Filing History |
| 2023-02-14 08:48 am Purchase |
2022-12-31 | 13G | ADMA Biologics, Inc. ADMA |
Teachers Advisors, LLC | 5,483,369 2.480% |
5,483,369 (New Position) |
Filing History |
| 2023-02-14 08:47 am Purchase |
2022-12-31 | 13G | ADMA Biologics, Inc. ADMA |
TIAA-CREF Investment Management, LLC | 5,483,369 2.480% |
5,483,369 (New Position) |
Filing History |